1 / 20

Oral contraceptive prescribing

Oral contraceptive prescribing. clinical pharmacology mechanism of action ADME interactions adverse reactions benefits and harms. what are they. around since late 1950’s social revolution progestogen /oestrogen variety of components and doses changes over time in both. oestrogen

robertcano
Télécharger la présentation

Oral contraceptive prescribing

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Oral contraceptive prescribing

  2. clinical pharmacology • mechanism of action • ADME • interactions • adverse reactions • benefits and harms

  3. what are they • around since late 1950’s • social revolution • progestogen /oestrogen • variety of components and doses • changes over time in both

  4. oestrogen ethinyoestradiol mestranol progestogen norethisterone norgestrel Levonorgestrel medroxyprogesterone ethynodiol diacetate gestodene desogestrel components

  5. doses • monophasic • oestrogen - up to 50g/day • progestogen - up to 1mg/day • biphasic • oestrogen: constant • progestogen: eg 11 days @50, 10 @125 g • triphasic • oestrogen 30/40/30 • progestogen 50/75/125

  6. clinical pharmacology • mechanism of action • inhibit secretion of FSH, LH - inhibit ovulation • additional actions on endometrium tubal motility, cervical mucosa

  7. clinical pharmacology • absorption • well absorbed orally • distribution • bound to plasma proteins • albumin, SBG, others

  8. metabolism • Oestrogens • first pass clearance • metabolised in liver, conjugated • excreted in the bile - (estradiol vs EE) • enterohepatic circulation • Progestogens • depends on which one - “natural” progestogen extensive first pass metabolism

  9. excretion • urinary • remember the bile duct STO HV PV CBD About 40-60 % of estrogen removed in the first pass through the liver HMW conjugates are excreted in bile

  10. interactions (1) • antibiotics • impaired absorption (effect on gut enzymes) reduced bacterial sulfatase leading to reduced entero-hepatic recycling • enzyme induction -> increased clearance, lower plasma estrogen concentrations (eg rifampicin, griseofulvin, anticonvulsants, St John’s Wort)

  11. interactions (2) • anticonvulsants • Older drugs are enzyme inducers -> increased clearance and reduced concentration and failure (phenytoin, phenobarbitone, primidone, carbamazepine). No effect of sodium valproate • Newer drug have variable effects (no change with gabapentin, lamotrigine, tiagabine, levetiracetam) (induction with topiramate and oxcarbazepine) • try higher dose estrogen pills, double product dosing • valproate less of a problem

  12. adverse reactions • estrogen excess • late cycle breakthrough bleeding • menorrhagia/dysmenorrhoea • nausea/vomiting • fluid retention • breast tenderness

  13. adverse reactions • progestogen excess • amenorrhoea • acne/oily skin • weight gain • mood changes • depressed libido • breast tenderness

  14. other risks • thromboembolic disorder • high dose oestrogen - Inman, dose response relationship • worse with other risk factors (age, smoking) • ?third generation progestogens • differentiating effects on VTE and other cardiovascular disease

  15. big picture risks • endometrial cancer • progestogen is protective • ovarian cancer • protective • breast cancer • jury out /data unconvincing • cervical cancer • confounded

  16. other benefits • reduction in menstrual flow - may lower incidence of anemia • reduction in dysmenorrhoea • possible reduction in auto-immune thyroid disease, rheumatoid arthritis • some protection against PID

  17. risk of nonfatal VTE

  18. other issues • compliance • gastro. • missing pills • alternative forms of hormonal contraception

  19. benefits effective contraception other health benefits long-term health and social impact harms immediate adverse effects risk of failure long-term health effects balance sheet

  20. other uses • morning after pill • EE 100mcg + norgestrel 1mg within 72 hours, 2 doses • Failure rate of about 1%

More Related